RxDoctor Payments Data

Robert Decaro

Physician Assistant · Hemet, CANPI 1285814632

Payments from drug & device makers

$2,397in general payments, 2019–2025

Across 112 payments — averaging $21.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$737
  • Collegium Pharmaceutical, Inc.$541
  • Relievant Medsystems, Inc.$180
  • Nalu Medical, Inc.$178
  • Forte Bio-pharma LLC$126
  • Vertex$100
  • plus $535 from 14 others

What the payments were for

  • Food & beverage$2,397100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,397 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl76$58,743
Xtampza ErOxycodone Myristate46$28,331
OxycontinOxycodone Hcl40$24,507
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen601$19,939
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen369$15,552
ZtlidoLidocaine33$13,604
MovantikNaloxegol Oxalate29$12,283
Emgality PenGalcanezumab-Gnlm16$10,830
Buprenorphine39$8,725
Oxycodone Hcl287$6,787
Lidocaine36$4,705
Gabapentin250$4,606
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl21$3,461
Diclofenac Sodium31$3,459
Morphine Sulfate ErMorphine Sulfate126$3,112

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$541$87,074122 claims
Hikma Pharmaceuticals USABuprenorphine, Buprenorphine-Naloxone, Buprenorphine Hcl, Morphine Sulfate$32$14,973135 claims
Scilex Pharmaceuticals Inc.Ztlido$74$13,60433 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Hemet

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →